Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for IceCure Medical Ltd. (ICCM:NASDAQ), powered by AI.
IceCure Medical Ltd. is currently trading at $2.13. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for IceCure Medical Ltd. on Alpha Lenz.
View IceCure Medical Ltd.'s valuation metrics on Alpha Lenz.
“IceCure Medical Ltd.'s ROE is -188.8%. Explore profitability and growth together.”
Ask for details →IceCure Medical Ltd. is a pioneering company in the medical equipment industry, specializing in innovative cryoablation technology. The primary focus of IceCure's product offerings is the minimally invasive treatment of cancerous tumors through extreme cold, a procedure known as cryoablation. This technology provides an alternative to traditional surgical methods, promoting faster recovery and reduced risk for patients. IceCure's solutions are particularly significant in the treatment of breast, kidney, lung, bone, and liver cancers, offering oncologists a versatile tool in precision medicine. Based in Israel, IceCure Medical Ltd. plays a crucial role in the medical technology market by continuously advancing its devices to enhance efficacy and safety. The company's innovations are particularly significant in healthcare markets striving for less invasive treatment options that maintain high standards of patient care. With a growing footprint in global healthcare, IceCure Medical Ltd. collaborates with medical professionals to expand its reach and impact in the fight against cancer. As such, IceCure Medical Ltd. stands out in the medical device sector as a leader in cryogenic solutions for oncology.
“IceCure Medical Ltd.'s ROE is -188.8%. Explore profitability and growth together.”
Ask for details →IceCure Medical Ltd. (ticker: ICCM) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 64 employees.
The current price is $2.13 with a P/E ratio of -x and P/B of -x.
ROE is -188.78% and operating margin is -446.70%. Annual revenue is $3M.